Pague Menos

Fortaleza, Brazil Founded: 1981 • Age: 45 yrs Listed
Pharmaceuticals, cosmetics, and health products are provided to customers.

About Pague Menos

Pague Menos is a publicly listed company based in Fortaleza (Brazil) founded in 1981 by Francisco Deusmar De Queiros. Pharmaceuticals, cosmetics, and health products are provided to customers. Pague Menos has raised $151.4 million across 1 funding round from investors including General Atlantic. Pague Menos has completed 1 acquisition, including Extrafarma. Its chief executive, as recorded, is Mario Henrique Alves De Queiros. Its website paguemenos.com.br draws about 8.6 million monthly visits. Pague Menos offers products and services including Medications and Health Services. Its focus areas include Pharmacies and Pharmaceutical Drugs. Its legal entity is Pague Menos Farmacias S.A.

Company details

Pague Menos was founded in 1981 in Fortaleza, Brazil, within the pharmaceuticals and health sector. Medications, dermocosmetics, and beauty items are supplied, along with categories such as baby and maternal care, fitness supplements, and hygiene products. Click-and-collect options are offered for convenience, while shopping by department or through curated virtual kits is facilitated across various brands.

  • Headquarters Fortaleza, Brazil
  • Founders Francisco Deusmar De Queiros
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health · Pharmacy
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website paguemenos.com.br
  • Social LinkedIn X Facebook
  • Legal Name Empreendimentos Pague Menos Sa
Key Metrics
  • Annual Revenue
    $2.72 B (USD)
    17.91
    as on Dec 31, 2025
  • Net Profit
    $47.52 M (USD)
    152.46
    as on Dec 31, 2025
  • EBITDA
    $251.93 M (USD)
    26.77
    as on Dec 31, 2025
  • Total Equity Funding
    $151.4M (USD)

    in 1 rounds

  • Latest Funding Round
    $151.4M (USD), Private Equity Round

    Dec 2015

  • Investors
  • Investments & Acquisitions

Products & Services of Pague Menos

Pague Menos offers a comprehensive portfolio of products and services, including Medications and Health Services.

Medications
Health Products

Medications are supplied for various conditions, including allergies and diabetes, to address health needs effectively.

Health Services
Wellness Services

Health services are delivered, such as vaccinations and clinical exams, to promote overall well-being and preventive care.

Funding Insights of Pague Menos

Pague Menos has successfully raised a total of $151.4M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $151.4 million completed in December 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $151.4M
  • Total Rounds 1
  • Last Round Private Equity Round β€” $151.4M
  • First Round $151.4M

    (Dec 2015)

  • Investors Count 1

All 1 funding rounds of Pague Menos with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2015$151.4MPrivate Equity Round–General Atlantic
–
Valuation history

1 investors in total: 1 institutional.

Investors in Pague Menos

Pague Menos has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include General Atlantic.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private equity fund focused on global markets
1980generalatlantic.comNew York, United States
Premium access

Investor details for Pague Menos

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Pague Menos

112 people are tracked at Pague Menos (16 in leadership, 9 in board & advisors, 87 in team).

NameRoleGroup
Francisco Deusmar De Queiros
FounderLeadership
Mario Henrique Alves De Queiros
CEOLeadership
Afro José Campos de Vasconcelos
Technology Infrastructure DirectorLeadership
Gianni Dias Gill
Operations DirectorLeadership
André Albuquerque Ferreira Pinto Bandeira
Operations DirectorLeadership
Renan Vieira Barbosa
Supply Chain DirectorLeadership
Renato Camargo Nascimento Junior
Chief Marketing OfficerLeadership
José Carlos Rafael de Assis Vasquez
COO & Chief Commercial OfficerLeadership
Mário Henrique Alves De Queirós
CEOLeadership
Luiz Renato Novais
CFO & Investor Relations OfficerLeadership
Rafael Cipriano Torres
Diretor De Estratégia - Escritório De Transformação (cto)Leadership
Felipe Farias
IT Consultant - Squad Digital New Products | Head VTEXLeadership
Plínio Girão
Data Director | Head Of Data | CDOLeadership
Pedro A.
Head Of StrategyLeadership
Renan Vieira
Commercial DirectorLeadership
Renato Camargo
Vice-president Of ConsumerLeadership
Carlos Henrique Alves De Queirós
Board MemberBoard & advisors
Francisco Leite Holanda Junior
Board MemberBoard & advisors
Rosilândia Maria Alves de Queirós Lima
Board MemberBoard & advisors
Manuela Vaz Artigas
Independent Board MemberBoard & advisors

92 more people are available in the full profile.

Premium access

Complete people profiles for Pague Menos

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Pague Menos

Pague Menos is a publicly listed company on the BMFBOVESPA with ticker symbol PGMN3 in Brazil, operating in the Retail trade sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date02 Sep 2020
  • Listed onBMFBOVESPA: PGMN3
  • Listed entityEmpreendimentos Pague Menos SA
  • Exchange sectorRetail trade
  • ISINBRPGMNACNOR8
  • Share price5.12 BRL (-6.91% on the day) · 2026-10-13
  • Market capitalisation3,687,155,855.00 BRL
  • Price to earnings10.5
  • EPS (diluted, trailing year)0.49 BRL
  • Dividend yield4.23%
  • Volume (last session)17,525,200

Financials of Pague Menos

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
202514.91B BRL260.3M BRL1.38B BRL
202412.64B BRL103.1M BRL1.09B BRL
202311.20B BRL219,000 BRL904.6M BRL
20229.19B BRL263.7M BRL759.2M BRL
20217.53B BRL164.5M BRL650.1M BRL
Premium access

Detailed financial statements for Pague Menos

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Pague Menos

Pague Menos has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Extrafarma.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Retailer of mother & baby health care and beauty products
extrafarma.com.brSao Paulo, Brazil1960May 2021β€’β€’β€’β€’
Premium access

Complete acquisition details for Pague Menos

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Pague Menos

4 dated milestones of Pague Menos across 40 years, from founding to its latest funding, stage changes and deals.

  1. Founded Pague Menos is founded.
  2. Funding First funding round of $151.4M.
  3. IPO Lists on the stock exchange (IPO).
  4. Acquisition Acquires Extrafarma.

Web traffic of Pague Menos

The website of Pague Menos (paguemenos.com.br) receives about 8.6M visits a month and ranks #7,006 among all websites worldwide, #105 in Pharmacy.

  • Monthly visits
    8.6M

    ▲ 9.1% vs previous month

  • Unique visitors
    4.3M

    per month

  • Global rank
    #7,006

    among all websites

  • Category rank
    #105

    Health · Pharmacy

Similar websites

Websites whose visitors overlap most with Pague Menos. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
drogaraia.com.br
drogaraia.com.br
100%
#5,981–
drogariasaopaulo.com.br
91%
9.3M#7,270View details
araujo.com.br
araujo.com.br
89%
#17,302–
drogasil.com.br
drogasil.com.br
86%
#3,968–
drogariaspacheco.com.br
drogariaspacheco.com.br
81%
#11,288–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Pague Menos

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Pague Menos

Premium access

Complete news archive for Pague Menos

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pague Menos

Pague Menos was founded in 1981 and raised its 1st funding round 34 years after it was founded.

Pague Menos is headquartered in Fortaleza, Brazil. It is registered at Fortaleza, Ceara, Brazil.

Mario Henrique Alves De Queiros is the CEO of Pague Menos, as recorded in our data.

Pague Menos is a funded company, having raised a total of $151.4M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $151.4M, raised on Dec 2015.

Annual revenue of Pague Menos is $2.72B as on Dec 31, 2025.

Pague Menos was founded in 1981 in Fortaleza, Brazil, within the pharmaceuticals and health sector. Medications, dermocosmetics, and beauty items are supplied, along with categories such as baby and maternal care, fitness supplements, and hygiene products. Click-and-collect options are offered for convenience, while shopping by department or through curated virtual kits is facilitated across various brands.

Pague Menos offers Medications and Health Services.

Yes, Pague Menos is publicly traded on BMFBOVESPA under the ticker symbol PGMN3.

Pague Menos has made 1 acquisition, including Extrafarma.

Pague Menos has 1 investor. Key investors include General Atlantic.

Pague Menos operates through Pague Menos Farmacias S.A..

The website of Pague Menos receives about 8.6 million visits a month and ranks #7,006 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available